Initiation strategies for renal-replacement therapy in the intensive care unit.
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The timing of renal-replacement therapy in critically ill patients who have acute kidney injury but no potentially life-threatening complication directly related to renal failure is a subject of debate. METHODS: In this multicenter randomized trial, we assigned patients with severe acute kidney injury (Kidney Disease: Improving Global Outcomes [KDIGO] classification, stage 3 [stages range from 1 to 3, with higher stages indicating more severe kidney injury]) who required mechanical ventilation, catecholamine infusion, or both and did not have a potentially life-threatening complication directly related to renal failure to either an early or a delayed strategy of renal-replacement therapy. With the early strategy, renal-replacement therapy was started immediately after randomization. With the delayed strategy, renal-replacement therapy was initiated if at least one of the following criteria was met: severe hyperkalemia, metabolic acidosis, pulmonary edema, blood urea nitrogen level higher than 112 mg per deciliter, or oliguria for more than 72 hours after randomization. The primary outcome was overall survival at day 60. RESULTS: A total of 620 patients underwent randomization. The Kaplan-Meier estimates of mortality at day 60 did not differ significantly between the early and delayed strategies; 150 deaths occurred among 311 patients in the early-strategy group (48.5%; 95% confidence interval [CI], 42.6 to 53.8), and 153 deaths occurred among 308 patients in the delayed-strategy group (49.7%, 95% CI, 43.8 to 55.0; P=0.79). A total of 151 patients (49%) in the delayed-strategy group did not receive renal-replacement therapy. The rate of catheter-related bloodstream infections was higher in the early-strategy group than in the delayed-strategy group (10% vs. 5%, P=0.03). Diuresis, a marker of improved kidney function, occurred earlier in the delayed-strategy group (P<0.001). CONCLUSIONS: In a trial involving critically ill patients with severe acute kidney injury, we found no significant difference with regard to mortality between an early and a delayed strategy for the initiation of renal-replacement therapy. A delayed strategy averted the need for renal-replacement therapy in an appreciable number of patients. (Funded by the French Ministry of Health; ClinicalTrials.gov number, NCT01932190.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prior research has suggested benefit [505] or harm [506] for “early” versus “delayed” initiation of RRT.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [506]
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
Hoste, E. A. J., Bagshaw, S. M., Bellomo, R., Cely, C. M., Colman, R., Cruz, D. N., Edipidis, K., Forni, L. G., Gomersall, C. D., Govil, D., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3934-7 · Cited by 3,061
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802639 · Cited by 1,759
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902413 · Cited by 1,473
Mehta, R. L., Cerdá, J., Burdmann, E. A., Tonelli, M., García-García, G., Jha, V., Susantitaphong, P., Rocco, M., Vanholder, R., Sever, M. S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60126-x · Cited by 1,154
Daily Hemodialysis and the Outcome of Acute Renal Failure
Schiffl, H., Lang, S. M., & Fischer, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010877 · Cited by 862 · cited 1×
“Congestive heart failure 24 (8) 32 (10)”
(2012) · Kidney International Supplements · doi:10.1038/kisup.2011.32 · Cited by 757
Vinsonneau, C., Camus, C., Combes, A., Costa de Beauregard, M. A., Klouche, K., Boulain, T., Pallot, J.-L., Chiche, J.-D., Taupin, P., Landais, P., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69111-3 · Cited by 685
Cited by
Items 301–400 of 1,000
Role of Loop Diuretic Challenge in Stage 3 Acute Kidney Injury
Sakhuja, A., Bandak, G. S. I., Barreto, E. F., Vallabhajosyula, S., Jentzer, J. C., Albright, R. C., & KASHANI, K. B. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.040 · Cited by 22
Gorham, J., Taccone, F. S., & Hites, M. (2022) · Antibiotics · doi:10.3390/antibiotics11050546 · Cited by 24
“, continuous venovenous hemofiltration—CVVH; continuous venovenous haemodialysis—CVVHD; continuous venovenous hemodiafiltration—CVVHD) techniques [14].”
MethodWei, E. Y., Vuong, K. T., Lee, E., Liu, L., Ingulli, E. G., & Coufal, N. G. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05782-0 · Cited by 21
Zhang, K., Zhang, H., Zhao, C., Hu, Z., Shang, J., Chen, Y., Huo, Y., Zhao, C., Ли, Б., & Guo, S. (2023) · European journal of medical research · doi:10.1186/s40001-023-01092-9 · Cited by 22
“The AKIKI trial categorized AKI stage 3 as the early group compared to patients with urgent reasons to commence CRRT and did not discover better mortality in the early group, most likely because it was too late to start CRRT [2].”
ResultPerioperative renal protection
Canet, E., & Bellomo, R. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000560 · Cited by 24
Scurt, F. G., Bose, K., Canbay, A. E., Mertens, P. R., & Chatzikyrkou, C. (2020) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1255-3413 · Cited by 22
Jaehne, A. K., & Rivers, E. P. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000002145 · Cited by 23
Strand, K., Søreide, E., Kirkegaard, H., Taccone, F. S., Grejs, A. M., Duez, C. H. V., Jeppesen, A. N., Storm, C., Rasmussen, B. S., Laitio, T. T., et al. (2020) · Resuscitation · doi:10.1016/j.resuscitation.2020.01.039 · Cited by 20
Bruno, R., Cammà, C., Caraceni, P., D’Amico, G., Grattagliano, I., Mura, V. L., Riggio, O., Schepis, F., Senzolo, M., Angeli, P., et al. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.06.021 · Cited by 25
Zampieri, F. G., da Costa, B. R., Vaara, S. T., Lamontagne, F., Rochwerg, B. N., Nichol, A. D., McGuinness, S., McAuley, D. F., Ostermann, M., Wald, R., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04120-y · Cited by 20
“These findings were consistent across a spectrum of priors used to inform our Bayesian models, including the results from prior trials with conflicting results [1, 2, 4].”
BackgroundMethodResultSelf-citationRobinson, A. M., Karvellas, C. J., Dionne, J. C., Featherstone, R. M., Sebastianski, M., Vandermeer, B., & Rewa, O. G. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01405-7 · Cited by 21
Pasin, L., Boraso, S., & Tiberio, I. (2019) · BMC Anesthesiology · doi:10.1186/s12871-019-0733-7 · Cited by 20
Bidirectional pressure: a mini review of ventilator-lung-kidney interactions
Kumar, A., Epler, K., DeWolf, S. E., Barnes, L. A., & Hepokoski, M. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1428177 · Cited by 21
Edrees, F., Katari, S., Baty, J., & Vijayan, A. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003508 · Cited by 23
Valdenebro, M., Martín-Rodriguez, L., Tarragón, B., Briales, P. S., & Portolés, J. M. (2020) · Nefrología · doi:10.1016/j.nefro.2020.07.016 · Cited by 32
Bénichou, N., Lebbah, S., Hajage, D., Martin‐Lefèvre, L., Pons, B., Boulet, É., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00843-3 · Cited by 21
“%) of the AKIKI trial [18].”
InfluentialSelf-citationLi, Y., Deng, X., Feng, J., Xu, B., Chen, Y., Li, Z., Guo, X., & Guan, T. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2176170 · Cited by 19
Jung, B., Huguet, H., Molinari, N., & Jaber, S. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073487 · Cited by 20
Besen, B. A. M. P., Romano, T. G., Mendes, P. V., Gallo, C. A., Zampieri, F. G., Nassar, A. P., & Park, M. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066617710914 · Cited by 20
“In order to calculate the neutrality zone, we chose a risk ratio reduction of 20% because it is compatible with many trials in ICU(23) and it represents an absolute mortality difference of around 10% to 15%, which we consider a reasonable effect size (and it was also used in previous (C)RRT initiation timing trials).(…”
BackgroundMethodLin, W., Lai, C., Chang, S.-P., & Wang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54777-9 · Cited by 20
Continuous renal replacement therapy in elderly with acute kidney injury
Medina-Liabres, K. R. P., & Kim, S. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.431 · Cited by 22
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
Virzì, G. M., Morisi, N., Paulo, C. O., Clementi, A., Ronco, C., & Zanella, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051570 · Cited by 20
Hardcastle, T. C., Gaarder, C., Balogh, Z. J., D’Amours, S. K., Davis, K. A., Gupta, A., Mohseni, S., Næss, P. A., Naidoo, S., Razek, T. S., et al. (2025) · World Journal of Surgery · doi:10.1002/wjs.70004 · Cited by 21
“Earlier RRT reduces the length of ICU and hospital stay but increases the risk of adverse events [226–228].”
Management of Acute Kidney Injury in Coronavirus Disease 2019
Shaikh, S. J., Umemoto, G. M., & Vijayan, A. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2020.08.002 · Cited by 20
Optimising the timing of renal replacement therapy in acute kidney injury
Cove, M. E., MacLaren, G., Brodie, D., & Kellum, J. A. (2021) · Critical Care · doi:10.1186/s13054-021-03614-5 · Cited by 18
“The first two of these studies were published in 2016; the ‘early versus delayed initiation of renal replacement therapy on mortality in critically ill patients with AKI’ (ELAIN) trial [6] and the ‘initiation strategies for renalreplacement therapy in the intensive care unit’ study from the ‘artificial kidney initiati…”
BackgroundMethodInfluentialPrescribing Continuous Kidney Replacement Therapy in Acute Kidney Injury: A Narrative Review
Verma, S. S., & Palevsky, P. M. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2021.05.006 · Cited by 19
Grolleau, F., Porcher, R., Barbar, S. D., Hajage, D., Bourredjem, A., Quenot, J., Dreyfuss, D., & Gaudry, S. (2022) · Critical Care · doi:10.1186/s13054-022-03936-y · Cited by 21
Self-citationHepatorenal Syndrome—Novel Insights into Diagnostics and Treatment
Badura, K., Frąk, W., Hajdys, J., Majchrowicz, G., Młynarska, E., Rysz, J., & Franczyk, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417469 · Cited by 26
dos Santos, T. O. C., Oliveira, M. A. D. S., Monte, J. C. M., Batista, M. C., Pereira, V. G., dos Santos, B. F. C., dos Santos, O. F. P., & Durão, M. D. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175897 · Cited by 24
Timing of Renal Replacement Therapy for Acute Kidney Injury
Karakala, N., & Tolwani, A. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618774257 · Cited by 18
Use of renal replacement therapy after out-of-hospital cardiac arrest in Denmark 2005–2013
Winther‐Jensen, M., Kjærgaard, J., Lassen, J. F., Køber, L., Torp-Pedersen, C. T., Hansen, S. M., Lippert, F. K., Kragholm, K. H., Christensen, E. F., & Hassager, C. (2018) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2018.1503707 · Cited by 22
Initiation of Renal-Replacement Therapy in the Intensive Care Unit
Gaudry, S., Hajage, D., & Dreyfuss, D. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1610500 · Cited by 18
Self-citationPrevention and Therapy of AKI in Asia: A Big Challenge
Kher, A., & Kher, V. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.08.004 · Cited by 19
Roedl, K., Jarczak, D., Fischer, M., Haddad, M., Boenisch, O., de Heer, G., Burdelski, C. M., Frings, D. P., Sensen, B., Karakas, M., et al. (2021) · Biomarkers · doi:10.1080/1354750x.2021.1905067 · Cited by 19
Bhatt, G. C., Das, R. R., & Satapathy, A. K. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000515129 · Cited by 18
Valdenebro, M., Martín-Rodriguez, L., Tarragón, B., Briales, P. S., & Portolés, J. M. (2021) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2021.05.003 · Cited by 26
Can this patient be safely weaned from RRT?
Klouche, K., Gibney, R. T. N., & Forni, L. G. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4948-0 · Cited by 18
Christiansen, S. H., Christensen, S., Pedersen, L. H., Gammelager, H., Layton, J. B., Brookhart, M. A., & Christiansen, C. F. (2017) · Critical Care · doi:10.1186/s13054-017-1903-y · Cited by 22
“In the recent multicenter AKIKI (Artificial Kidney Initiation in Kidney Injury) trial, 619 patients with AKI stage 3 who required mechanical ventilation, catecholamine infusion, or both were randomized either to immediate RRT (early) or to treatment being withheld until absolute indications developed (late) [29].”
BackgroundHwang, S., Kang, D., Park, H., Kim, Y., Güallar, E., Jeon, J., Lee, J. E., Huh, W., Suh, G. Y., Cho, J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092392 · Cited by 17
“5%) in the Artificial Kidney Initiation in Kidney Injury (AKIKI) trial [28], which supports our hypothesis.”
ResultLi, X., Bai, M., Yu, Y., Ma, F., Zhao, L., Li, Y., Wu, H., Zhou, L., & Sun, S. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2132170 · Cited by 18
Camous, L., Surel, A., Kallel, H., Nicolas, M., Martino, F., Valette, M., Demoule, A., & Pommier, J. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01128-7 · Cited by 19
Schiefer, J., Lichtenegger, P., Berlakovich, G. A., Plöchl, W., Krenn, C. G., Baron, D. M., Baron‐Stefaniak, J., & Faybik, P. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1456-1 · Cited by 17
Leaf, D. E., & Waikar, S. S. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01180119 · Cited by 17
Tanaka, T., Mori, M., Sekino, M., Higashijima, U., Takaki, M., Yamashita, Y., Kakiuchi, S., Tashiro, M., Morimoto, K., Tasaki, O., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93649-z · Cited by 18
Lemerle, M., Schmidt, A., Seegers, V., Kouatchet, A., Moal, V., Raimbault, M., Orvain, C., Augusto, J., & Demiselle, J. (2022) · Journal of Nephrology · doi:10.1007/s40620-022-01263-7 · Cited by 17
“The discrepancy in the frequencies of malignant hemopathies between our study and others may be explained by the ICU-predominant population in previous studies.”
BackgroundInfluentialDequin, P., Aubron, C., Faure, H., Garot, D., Guillot, M., Hamzaoui, O., Lemiale, V., Maizel, J., Mootien, J., Osman, D., et al. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01155-4 · Cited by 20
“, in which nearly 50% of patients had improved kidney function by the 72nd hour [104].”
BackgroundSelf-citationDruml, W., Joannidis, M., John, S., Jörres, A., Schmitz, M., Kielstein, J. T., Kindgen‐Milles, D., Oppert, M., Schwenger, V., Willam, C., et al. (2018) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-018-0427-9 · Cited by 19
Tavris, B. S., Morath, C. P., Rupp, C., Szudarek, R., Uhle, F., Sweeney, T. E., Liesenfeld, O., Fiedler, M. O., Dubler, S., Zeier, M., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05361-3 · Cited by 20
“An example in this context is the timing of KRT. Multiple randomized controlled trials have shown that early initiation of KRT in both septic and non-septic patients does not improve outcomes [43, 44].”
Gunning, S., Kutuby, F., Rose, R., Trevino, S., Song, T. H., & Koyner, J. L. (2020) · Kidney360 · doi:10.34067/kid.0000402019 · Cited by 17
Anaemia and acute kidney injury: the tip of the iceberg?
Lombardi, Y., Ridel, C., & Touzot, M. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa202 · Cited by 16
“Whether early initiation of renal replacement therapy could improve clinical outcomes is still controversial [11, 12].”
BackgroundRenal Dysfunction in Cirrhosis: Critical Care Management
Rela, M., Kaliamoorthy, I., Rajakumar, A., & Appuswamy, E. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23721 · Cited by 20
Comprehensive Management of Blood Pressure in Patients with Septic AKI
Deng, J., Li, L., Feng, Y., & Yang, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031018 · Cited by 19
“There was no significant difference in mortality between the two groups, even though delayed treatment avoided the need for kidney replacement therapy in a significant number of patients [109].”
BackgroundRambaud, T., Hajage, D., Dreyfuss, D., Lebbah, S., Martin‐Lefèvre, L., Louis, G., Moschietto, S., Beauport, D. T., Combe, B. L., Pons, B., et al. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07339-1 · Cited by 16
“Several large randomized controlled trials have shown that, in the absence of life-threatening complications of AKI (hyperkalemia, metabolic acidosis, pulmonary edema due to fluid overload), RRT can be safely postponed allowing for likely reduction of risk of harm and health expenditures [10–13].”
Self-citationPrevention of acute kidney injury.
Meersch, M., Volmering, S., & Zarbock, A. (2017) · Bailliere's Best Practice & Research. Clinical Anaesthesiology · doi:10.1016/j.bpa.2017.08.002 · Cited by 38
Managing Chloride and Bicarbonate in the Prevention and Treatment of Acute Kidney Injury
Haines, R. W., Kirwan, C. J., & Prowle, J. R. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.06.007 · Cited by 18
Andonovic, M., Shemilt, R., Sim, M. R., Traynor, J. P., Shaw, M., Mark, P. B., & Puxty, K. A. (2020) · Journal of the Intensive Care Society · doi:10.1177/1751143720901688 · Cited by 17
“In [28], the ‘early’ group was segmented into high- and low-volume haemofiltration; in [13], values were given for survivors/non-survivors in both ‘early’ and ‘late’ groups;”
BackgroundMethodResultInfluentialNavas, A., Ferrer, R., Martínez, M. L., Gomà, G., Gili, G., Masip, J., Suarez, D. L., & Artigas, A. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0465-8 · Cited by 16
McCoy, I. E., Weinhandl, E. D., Hussein, W. F., & Hsu, C. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000225 · Cited by 15
Continuous renal replacement therapy: individualization of the prescription
Haines, R. W., Kirwan, C. J., & Prowle, J. R. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000546 · Cited by 16
Naorungroj, T., Neto, A. S., Yanase, F., Eastwood, G. M., Wald, R., Bagshaw, S. M., & Bellomo, R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005018 · Cited by 16
Bidar, F., Luyt, C. E., Schneider, A. G., Ostermann, M., Mauriat, P., Javouhey, É., Fellahi, J.-L., & Rimmele, T. R. (2021) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2021.100971 · Cited by 17
Jiang, W., Liao, T., Yu, J., Shao, J., & Zheng, R. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03511-6 · Cited by 16
Baek, S. D., Yu, H., Shin, S., Park, H.-S., Kim, M.-S., Kim, S. M., Lee, E. K., & Chang, J. W. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.12.014 · Cited by 15
“Delaying the initiation of therapy has been shown to allow many patients to recover from AKI and avoid the need for RRT [8].”
BackgroundResultGaudry, S., Verney, C., Hajage, D., Ricard, J.-D., & Dreyfuss, D. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5210-0 · Cited by 15
“Of the 619 patients included in AKIKI [3], 60 (10”
BackgroundMethodSelf-citationInage, S., Nakamura, S., Isoe, Y., Okamoto, S., Uetake, S., Murakami, M., Yamaguchi, A., Morishima, M., Nei, T., Ise, Y., et al. (2019) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2020_87-203 · Cited by 15
Orieux, A., Prezelin‐Reydit, M., Prével, R., Combe, C., Gruson, D., Boyer, A., & Rubin, S. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac054 · Cited by 17
Self-citationVaara, S. T., Neto, A. S., Bellomo, R., Adhikari, N. K. J., Dreyfuss, D., Gallagher, M., Gaudry, S., Hoste, E. A. J., Joannidis, M., Pettilä, V., et al. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001053 · Cited by 20
Self-citationGrolleau, F., Petit, F., Gaudry, S., Diard, É., Quenot, J., Dreyfuss, D., Tran, V.-T., & Porcher, R. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae004 · Cited by 17
Self-citationJeong, R., Bagshaw, S. M., Ghamarian, E., Harvey, A. K., Joannidis, M., Kirkham, B., McAuley, D. F., Ostermann, M., Quenot, J., Young, P. J., et al. (2025) · Critical Care Medicine · doi:10.1097/ccm.0000000000006616 · Cited by 15
Schurr, J. W., Szumita, P. M., & DeGrado, J. R. (2017) · Shock · doi:10.1097/shk.0000000000000864 · Cited by 14
“trial did demonstrate that early vasopressin use was associated with significantly less need for renal replacement therapy, a clinically relevant endpoint that can reduce the occurrence of catheter-related bloodstream infections (103).”
BackgroundIndications and Timing of Continuous Renal Replacement Therapy Application
Bagshaw, S. M., & Wald, R. (2018) · Contributions to nephrology · doi:10.1159/000485598 · Cited by 14
KIDNEY DYSFUNCTION IN CRITICALLY ILL PATIENTS
Polushin, Y. S., & Соколов, Д. В. (2018) · Messenger of Anesthesiology and Resuscitation · doi:10.21292/2078-5658-2018-15-5-54-64 · Cited by 14
Gomes, B. C., Silva, J. M., & Tuon, F. F. (2020) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358120934215 · Cited by 14
Suassuna, J. H. R., de Lima, E. Q., Rocha, E., Castro, A., Burdmann, E. A., do Carmo, L. P. D. F., Yu, L., Younes-Ibrahim, M., Betônico, G. N., Neto, A. L. C., et al. (2020) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2020-s107 · Cited by 17
Fang, J., Wang, M., Gong, S., Cui, N., & Xu, L. Z. (2021) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13727 · Cited by 14
Extracorporeal Treatments in Patients with Acute Kidney Injury and Sepsis
Marengo, M., Dellepiane, S., & Cantaluppi, V. (2017) · Contributions to nephrology · doi:10.1159/000468912 · Cited by 14
Schwenger, V., Kindgen‐Milles, D., Willam, C., Jörres, A., Druml, W., Czock, D., Klein, S., Oppert, M., Schmitz, M., Kielstein, J. T., et al. (2018) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-018-0418-x · Cited by 14
Shawwa, K., Kompotiatis, P., Bobart, S. A., Mara, K. C., Wiley, B. M., Jentzer, J. C., & KASHANI, K. B. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.12.010 · Cited by 16
Romagnoli, S., & Ricci, Z. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.08.55 · Cited by 14
“on the New England Journal of Medicine (NEJM) failed to reach the benefit in overall survival at day 60 as primary outcome (5): the Artificial Kidney Initiation in Kidney Injury (AKIKI) trial.”
BackgroundTiming of Dialysis in Sepsis and Acute Respiratory Distress Syndrome
Lameire, N. H., & Vanmassenhove, J. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201801-0129ed · Cited by 14
Raina, R., KASHANI, K. B., Sethi, S. K., Mok, Q., Kakajiwala, A. K., Parikh, S. M., Doshi, K., Hu, J., Alhasan, K. A., Tavares, M. D. S., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05517-1 · Cited by 14
“Furthermore, the 2016 Artificial Kidney Initiation in Kidney Injury study group showed that spontaneous UOP > 500 ml/24hr was associated with optimal CRRT liberation [31].”
Association of continuous kidney replacement therapy timing and mortality in critically ill children
Banigan, M., Keim, G. P., Traynor, D., Yehya, N., Lindell, R. B., & Fitzgerald, J. C. (2024) · Pediatric Nephrology · doi:10.1007/s00467-024-06320-w · Cited by 14
Li, C., Wang, Y., Wang, X., Shao, C., Xin, M., Xu, B., Hao, X., Jia, M., Yang, F., Wang, L., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14967 · Cited by 13
Severe bleeding events among critically ill patients with haematological malignancies
Vigneron, C., Devautour, C., Charpentier, J., Birsen, R., Jamme, M., & Pène, F. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01383-2 · Cited by 13
“It should be mentioned that our current management of acute renal failure has recently evolved towards more delayed initiation of renal replacement therapy, with higher serum urea thresholds likely to impact on coagulation [36].”
BackgroundRecovery of kidney function in acute kidney injury
Patschan, D., Stasche, F., Erfurt, S., Matyukhin, I., Ritter, O., & Safi, W. (2025) · Journal of Nephrology · doi:10.1007/s40620-025-02220-w · Cited by 17
“Contrasting data were collected in the AKIKI study [47].”
Complicated Burn Resuscitation
Harrington, D. T. (2016) · Critical Care Clinics · doi:10.1016/j.ccc.2016.06.005 · Cited by 13
RRT in AKI: Start Early or Wait?
Liu, K. D., & Palevsky, P. M. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06690616 · Cited by 15
Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus‐2 infection
Rosen, H. R., O'Connell, C. L., Nadim, M. K., DeClerck, B. K., Sheibani, S., DePasquale, E. C., Sanossian, N., Blodget, E., & Angell, T. E. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26595 · Cited by 15
Acute Kidney Injury in Sepsis: Evidence From Asia
Yoshimoto, K., Komaru, Y., Iwagami, M., & Doi, K. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.08.005 · Cited by 13
The effectiveness of vitamin C for patients with severe viral pneumonia in respiratory failure
Lee, S., Lim, C., Koh, Y., Huh, J. W., Lee, J. S., & Hong, S. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-1306 · Cited by 17
Billings, F. T., Lopez, M. G., & Shaw, A. (2021) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01894-z · Cited by 13
Sekandarzad, A., Weber, E., Prager, E. P., Graf, E., Bettinger, D., Wengenmayer, T., & Supady, A. (2022) · Trials · doi:10.1186/s13063-022-06139-6 · Cited by 16
Fan, Y., Chen, L., Jiang, S., Huang, Y., Leng, Y., & Gao, C. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.03.004 · Cited by 13
Morzywołek, P., Steen, J., Vansteelandt, S., Decruyenaere, J. M. A., Sterckx, S., & Biesen, W. V. (2022) · Critical Care · doi:10.1186/s13054-022-04252-1 · Cited by 18
Quality of life after acute kidney injury
McNicholas, B., Akcan‐Arikan, A., & Ostermann, M. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001090 · Cited by 17
Management of renal failure in end‐stage liver disease: A critical appraisal
Cheng, X. S., Tan, J. C., & Kim, W. R. (2016) · Liver Transplantation · doi:10.1002/lt.24609 · Cited by 13
“In general AKI and CKD, early versus late dialysis initiation in patients have been compared in multiple prospective, interventional trials (eg, 2 recent examples for AKI((44)) and CKD((45))).”
BackgroundManejo actual de las terapias continuas de reemplazo renal: Estudio epidemiológico multicéntrico
Tomasa-Irriguible, T. M., Sabater‐Riera, J., de Briñas, E. P. L., Fort, J., Cora, M. J. L., Antònio, J. R., Navas, A., Ballujera, P. O., Serviá, L., de Molina, F. J. G., et al. (2016) · Medicina Intensiva · doi:10.1016/j.medin.2016.07.002 · Cited by 16
“Edad [años, mediana (mín-máx)] 66,2 (16,1-87,2)”
Hospital Variation in Renal Replacement Therapy for Sepsis in the United States
Valley, T. S., Nallamothu, B. K., Heung, M., Iwashyna, T. J., & Cooke, C. R. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002878 · Cited by 14
Broman, M., Bell, M., Joannès-Boyau, O., & Ronco, C. (2018) · Blood Purification · doi:10.1159/000489213 · Cited by 13
Metadata
- Authors
- Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., de Prost, N., Lautrette, A., Bretagnol, A., Mayaux, J., Nseir, S., Megarbane, B., Thirion, M., Forel, J.-M., Maizel, J., Yonis, H., Markowicz, P., Thiery, G., Tubach, F., Ricard, J.-D., & Dreyfuss, D.
- Affiliations
- Inserm (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-07-14
- Volume
- 375
- Issue
- 2
- Pages
- 122-133
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2380810418
- Cited by
- 1,243
- References
- 41
- Citations by year
- 2026: 114 · 2025: 128 · 2024: 115 · 2023: 80 · 2022: 126 · 2021: 127 · 2020: 130 · 2019: 128 · 2018: 124 · 2017: 115 · 2016: 50
- FWCI
- 139.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- acute kidney injury, renal replacement therapy, dialysis initiation timing, critically ill patients, intensive care unit, mortality, catheter-related bloodstream infection, diuresis, mechanical ventilation, catecholamine infusion, oliguria, hyperkalemia, metabolic acidosis, pulmonary edema, blood urea nitrogen, KDIGO staging
- MeSH terms
- Aged, Follow-Up Studies, Humans, Intensive Care Units, Middle Aged, Severity of Illness Index, Urine, Renal Replacement Therapy, Kaplan-Meier Estimate, Acute Kidney Injury, Time-to-Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.